Loading...
Keywords
Last Name
Institution

Tamorah Lewis

Concepts (113)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
5
2018
81
2.400
Why?
Bronchopulmonary Dysplasia
4
2020
76
1.860
Why?
Precision Medicine
3
2019
39
1.680
Why?
Analgesics, Opioid
5
2015
45
1.580
Why?
Neonatal Abstinence Syndrome
4
2015
6
1.500
Why?
Pharmacogenetics
5
2018
115
1.360
Why?
Infant, Newborn, Diseases
2
2018
37
1.320
Why?
Opioid-Related Disorders
2
2015
13
1.250
Why?
Infant, Newborn
12
2020
967
1.230
Why?
Dexamethasone
3
2019
31
1.210
Why?
Indomethacin
2
2018
6
0.970
Why?
Humans
16
2020
5862
0.970
Why?
Ductus Arteriosus, Patent
2
2018
7
0.960
Why?
Cultural Diversity
1
2020
6
0.870
Why?
Respiration
1
2019
10
0.840
Why?
Internship and Residency
1
2020
35
0.830
Why?
Infant, Extremely Low Birth Weight
1
2019
24
0.820
Why?
Drug Administration Schedule
2
2018
50
0.820
Why?
Pharmacists
1
2019
3
0.820
Why?
Career Choice
1
2019
4
0.810
Why?
Receptors, Corticotropin-Releasing Hormone
1
2018
2
0.810
Why?
Research Personnel
1
2019
8
0.810
Why?
Infant, Extremely Premature
1
2019
37
0.800
Why?
Adrenal Cortex Hormones
1
2018
28
0.790
Why?
Cholagogues and Choleretics
1
2018
1
0.790
Why?
Ursodeoxycholic Acid
1
2018
1
0.790
Why?
Jaundice, Obstructive
1
2018
1
0.790
Why?
Phenobarbital
1
2018
3
0.790
Why?
Jaundice, Neonatal
1
2018
2
0.790
Why?
Opiate Substitution Treatment
2
2015
3
0.770
Why?
Infant, Premature
5
2018
144
0.740
Why?
Pharmaceutical Preparations
1
2018
40
0.730
Why?
Polymorphism, Single Nucleotide
1
2018
206
0.720
Why?
Pediatrics
1
2020
219
0.680
Why?
Female
9
2019
3373
0.650
Why?
Iatrogenic Disease
1
2015
6
0.640
Why?
Maternal Exposure
1
2015
9
0.640
Why?
Prenatal Exposure Delayed Effects
1
2015
19
0.620
Why?
Genetic Variation
1
2015
151
0.570
Why?
Male
7
2019
3283
0.550
Why?
Dose-Response Relationship, Drug
3
2018
109
0.490
Why?
Infant, Premature, Diseases
2
2020
51
0.400
Why?
Glucocorticoids
2
2018
35
0.390
Why?
Phenotype
2
2018
210
0.340
Why?
Risk Assessment
2
2018
156
0.330
Why?
Genetic Predisposition to Disease
2
2018
151
0.320
Why?
Risk Factors
2
2018
387
0.310
Why?
United States
2
2020
678
0.300
Why?
Treatment Outcome
3
2019
601
0.240
Why?
Minority Groups
1
2020
12
0.220
Why?
Ethnic Groups
1
2020
45
0.210
Why?
Metabolic Networks and Pathways
1
2019
10
0.210
Why?
Metabolomics
1
2019
10
0.210
Why?
Prospective Studies
2
2019
455
0.200
Why?
Perinatology
1
2019
2
0.200
Why?
Ohio
1
2019
6
0.200
Why?
Pharmacology, Clinical
1
2019
4
0.200
Why?
Surface-Active Agents
1
2018
3
0.200
Why?
Introns
1
2018
10
0.200
Why?
Genetic Markers
1
2018
18
0.200
Why?
Fellowships and Scholarships
1
2019
16
0.200
Why?
Kansas
1
2019
45
0.200
Why?
Hydrocortisone
1
2018
6
0.200
Why?
Biomarkers
1
2019
119
0.200
Why?
Anti-Inflammatory Agents
1
2018
14
0.200
Why?
Risk
1
2018
39
0.200
Why?
Multivariate Analysis
1
2018
80
0.200
Why?
Neonatology
1
2019
29
0.200
Why?
Urine Specimen Collection
1
2018
2
0.200
Why?
Glucuronides
1
2018
6
0.200
Why?
Bilirubin
1
2018
15
0.200
Why?
Ibuprofen
1
2018
2
0.190
Why?
Acetaminophen
1
2018
25
0.190
Why?
Attitude of Health Personnel
1
2019
89
0.190
Why?
Gestational Age
1
2018
94
0.190
Why?
Disease Models, Animal
1
2018
78
0.190
Why?
Pharmacokinetics
1
2018
19
0.190
Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
23
0.180
Why?
Genotype
1
2018
289
0.180
Why?
Infant
2
2019
1351
0.180
Why?
Hospitals, Pediatric
1
2019
165
0.180
Why?
Pregnancy
2
2015
262
0.180
Why?
Maternal-Fetal Exchange
1
2015
11
0.160
Why?
Pharmacoepidemiology
1
2015
1
0.160
Why?
Tissue Distribution
1
2015
25
0.160
Why?
Medication Therapy Management
1
2015
8
0.160
Why?
Biotransformation
1
2015
58
0.160
Why?
Tandem Mass Spectrometry
1
2015
24
0.160
Why?
Animals
1
2018
877
0.160
Why?
Chromatography, High Pressure Liquid
1
2015
59
0.160
Why?
Retrospective Studies
2
2018
1014
0.150
Why?
Cross-Sectional Studies
1
2015
252
0.150
Why?
Length of Stay
1
2015
212
0.140
Why?
Methadone
2
2012
5
0.140
Why?
Clonidine
1
2009
1
0.100
Why?
Opium
1
2009
1
0.100
Why?
Adrenergic alpha-Agonists
1
2009
2
0.100
Why?
Heroin
1
2009
2
0.100
Why?
Severity of Illness Index
1
2020
150
0.050
Why?
Respiration, Artificial
1
2018
41
0.050
Why?
Morphine Derivatives
1
2015
1
0.040
Why?
Hydromorphone
1
2015
2
0.040
Why?
Observer Variation
1
2015
17
0.040
Why?
Morphine
1
2015
11
0.040
Why?
Reference Standards
1
2015
11
0.040
Why?
Guidelines as Topic
1
2015
18
0.040
Why?
Linear Models
1
2015
61
0.040
Why?
Buprenorphine
1
2012
1
0.030
Why?
Serotonin Uptake Inhibitors
1
2012
7
0.030
Why?
Immunotherapy
1
2012
14
0.030
Why?
Heart Rate
1
2009
22
0.030
Why?
Drug Therapy, Combination
1
2009
47
0.030
Why?
Blood Pressure
1
2009
50
0.030
Why?
Lewis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_